Regression/Eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide

Malignant gliomas have poor prognosis and urgently require new therapies. Activating Transcription Factor 5 (ATF5) is highly expressed in gliomas, and interference with its expression/function precipitates targeted glioma cell apoptosis in vitro and in vivo. We designed a novel deliverable truncated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cates, Charles C., Arias, Angelo D., Wong, Lynn S. Nakayama, Lamé, Michael W., Sidorov, Maxim, Cayanan, Geraldine, Rowland, Douglas J., Fung, Jennifer, Karpel-Massler, Georg, Siegelin, Markus D., Greene, Lloyd A., Angelastro, James M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914317/
https://ncbi.nlm.nih.gov/pubmed/26863637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars